Clinical outcomes associated with the use of oral semaglutide in an adult population with type 2 diabetes in Canada: a prospective real-world study (PIONEER REAL Canada)

被引:0
|
作者
Reichert, S. M. [1 ,2 ]
Amadid, H. [3 ]
Braae, U. C. [3 ]
Bradley, R. M. [4 ]
Kim, J. [5 ]
Soo, V. [6 ]
Yale, J. -F. [7 ]
Jain, A. [8 ]
机构
[1] Western Univ, Schulich Sch Med & Dent, Dept Family Med, London, ON, Canada
[2] Western Univ, Schulich Sch Med & Dent, Ctr Studies Family Med, London, ON, Canada
[3] Novo Nordisk AS, Soborg, Denmark
[4] Novo Nordisk Inc, Mississauga, ON, Canada
[5] Univ Calgary, Dept Family Med, Calgary, AB, Canada
[6] Western Univ, Dept Family Med, London, ON, Canada
[7] McGill Univ, McGill Univ Hlth Ctr, Montreal, PQ, Canada
[8] Univ British Columbia, Div Endocrinol & Metab, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
668
引用
收藏
页码:S338 / S339
页数:2
相关论文
共 50 条
  • [41] Semaglutide Once Weekly In Persons with Type 2 Diabetes: Real-World Analysis of the Colombian Diabetes Registry (COL-REAL 1 Study)
    Mario Balcazar, Carlos
    Zambrano, Jose
    Felipe Garcia, Andres
    Eugenia Casanova, Maria
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 69 - 70
  • [42] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Wolffenbuttel, Bruce H. R.
    Brugts, Michel P.
    Catarig, Andrei-Mircea
    Clark, Alice
    Kok, Maarten
    Lieverse, Aloysius G.
    van Soest, Jaap
    ADVANCES IN THERAPY, 2023, 40 (03) : 920 - 933
  • [43] Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study
    Bruce H. R. Wolffenbuttel
    Michel P. Brugts
    Andrei-Mircea Catarig
    Alice Clark
    Maarten Kok
    Aloysius G. Lieverse
    Jaap van Soest
    Advances in Therapy, 2023, 40 : 920 - 933
  • [44] Oral versus subcutaneous semaglutide weight loss outcomes after two years among patients with type 2 diabetes in a real-world database
    Kwon, Jimmy
    Thiara, Diana
    Watanabe, Jonathan H.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2025, 20 (02) : 163 - 168
  • [45] Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study
    Vuohijoki, Anni
    Mikkola, Ilona
    Jokelainen, Jari
    Keinanen-Kiukaanniemi, Sirkka
    Winell, Klas
    Frittitta, Lucia
    Timonen, Markku
    Hagnas, Maria
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2020, 11
  • [46] Efficacy and Safety in a Real-World Study of the New Oral Formulation of Semaglutide in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
    Vidas, Maria Marques
    Lopez-Sanchez, Paula
    Sanchez-Briales, Paula
    Illazquez, Maria Victoria Lopez
    Portoles, Jose
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (17)
  • [47] Effectiveness and safety of daily oral semaglutide in people with type 2 diabetes mellitus switching from sulfonylureas: A real-world retrospective study
    Costa, Silvana
    Miranda, Cesare
    Elefante, Antonia
    Vallone, Valeria
    Vinci, Carmela
    Borroni, Francesca
    Brandoni, Gabriele
    Labate, Antonio M.
    Lo Pomo, Feliciano
    Strazzabosco, Marco
    DIABETES OBESITY & METABOLISM, 2025,
  • [48] A Real-World Observational Study of the Use and Associated Costs of Treating Neuroendocrine Tumors With Somatostatin Analogs in Canada
    Cheung, Winson Y.
    LaForty, Callahan
    Liovas, Anna
    McKechnie, Heather
    Loree, Jonathan M.
    PANCREAS, 2022, 51 (09) : 1146 - 1152
  • [49] Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Denmark/Sweden multicentre, prospective, observational study
    Ekberg, Neda Rajamand
    Bodholdt, Ulrik
    Catarig, Andrei-Mircea
    Catrina, Sergiu-Bogdan
    Grau, Katrine
    Holmberg, Cecilia Nagorny
    Klanger, Boris
    Knudsen, Soren Tang
    PRIMARY CARE DIABETES, 2021, 15 (05) : 871 - 878
  • [50] Use of Linagliptin for the Management of Medicine Department Inpatients with Type 2 Diabetes in Real-World Clinical Practice (Lina-Real-World Study)
    Perez-Belmonte, Luis M.
    Gomez-Doblas, Juan J.
    Millan-Gomez, Mercedes
    Lopez-Carmona, Maria D.
    Guijarro-Merino, Ricardo
    Carrasco-Chinchilla, Fernando
    de Teresa-Galvan, Eduardo
    Jimenez-Navarro, Manuel
    Rosa Bernal-Lopez, M.
    Gomez-Huelgas, Ricardo
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (09)